Angiogenesis is a key process in regenerative medicine generally, as well as in the specific field of nerve regeneration. However, no convenient and objective method for evaluating the angiogenesis of tissue-engineered nerves has been reported. In this study, tissue-engineered nerves were constructed in vitro using Schwann cells differentiated from rat skin-derived precursors as supporting cells and chitosan nerve conduits combined with silk fibroin fibers as scaffolds to bridge 10-mm sciatic nerve defects in rats. Four weeks after surgery, three-dimensional blood vessel reconstructions were made through MICROFIL perfusion and micro-CT scanning, and parameter analysis of the tissue-engineered nerves was performed. New blood vessels grew into the tissue-engineered nerves from three main directions: the proximal end, the distal end, and the middle. The parameter analysis of the three-dimensional blood vessel images yielded several parameters, including the number, diameter, connection, and spatial distribution of blood vessels. The new blood vessels were mainly capillaries and microvessels, with diameters ranging from 9 to 301 μm. The blood vessels with diameters from 27 to 155 μm accounted for 82.84% of the new vessels. The microvessels in the tissue-engineered nerves implanted in vivo were relatively well-identified using the MICROFIL perfusion and micro-CT scanning method, which allows the evaluation and comparison of differences and changes of angiogenesis in tissue-engineered nerves implanted in vivo. 
Introduction
Blood vessels, which are spread throughout the body providing oxygen and nutrients and removing metabolites, are an important support system (Carmeliet and Jain, 2011; Potente et al., 2011) . Encouraging faster and more efficient angiogenesis in regenerative tissues and organs can improve their survival and physiological functions, making them better physiological substitutes (Goerke et al., 2015; Jiang et al., 2015) . In the fields of regenerative medicine and regenerative tissue engineering, the focus of research has increasingly been on establishing a blood supply for the regenerated tissues and organs (Dew et al., 2015; Osborn et al., 2015; Shafiq et al., 2015; Unger et al., 2015) , which is one critical bottleneck in regenerative medicine.
Our group has focuses on the research and exploration of peripheral nerve tissue regeneration (Wang et al., 2005 (Wang et al., , 2012 (Wang et al., , 2014b Hu et al., 2013; Gu et al., 2014; Li et al., 2015; Zhou et al., 2015) because of the critical importance of angiogenesis in tissue-engineered nerves. Blood vessels can be encouraged to grow into chitosan nerve conduits, the basis of creating tissue-engineered nerves, through the innovative use of certain key technologies. However, the objective and comprehensive imaging and evaluation of neovascularization in tissue-engineered nerves remain technical problems. In the present study, we report a better method for evaluating angiogenesis in tissue-engineered nerves. Three-dimensional reconstruction of the blood vessels in implanted tissue-engineered nerves is difficult because the microvessels are denser and thinner than those found in normal spinal cords and sciatic nerves. As a contrast agent, the MICROFIL complex has several advantages such as allowing better imaging of the microvessels, better filing, and less shrinkage after curing than other contrast agents.
The three-dimensional reconstruction of blood vessels in tissue-engineered nerves bridging 10-mm sciatic nerve defects was observed in the present study for the first time using MICROFIL perfusion and micro-CT scanning. This method provided relevant data on the reconstructed blood vessels for understanding the mechanisms underlying angiogenesis and elevating the angiogenesis in tissue-engineered nerves.
Materials and Methods

Fabrication of chitosan nerve conduits
Chitosan (Nantong Xincheng Biochemical Company, Nantong, Jiangsu Province, China) was purified twice through dissolution in 10 g of acetic acid, filtration, precipitation with 50 g of NaOH, and finally drying in a vacuum at room temperature. The degree of chitosan deacetylation was 92.3%, as measured by titration. After 5 g of chitosan had completely dissolved in 100 mL of 0.15 M hydrochloric acid, 10% gelatin was added, followed by 5 g of chitin powder, with stirring to form an opaque viscous liquid. The chitin/ chitosan mixture was then injected into stainless-steel casting molds, which were then sealed and placed at −12°C for 2-4 hours. Next, the frozen gels were removed and soaked in 4 M NaOH for 4 hours to neutralize any remaining lactic acid and to complete the solidification. The conduits were then rinsed repeatedly with distilled water to remove any residual NaOH and sodium lactate and lyophilized under a 35-45 mTorr vacuum for 20 hours. The resulting porous conduits were 2 mm inner diameter, 3 mm outer diameter, and 80 mm long (Yang et al., 2011) .
Ethics statement
All experimental protocols were approved by the Administration Committee of Experimental Animals, Jiangsu Province, China, in accordance with the guidelines of the Institutional Animal Care and Use Committee, Nantong University, China. Institutional Animal Care and Use Committee approval was obtained before beginning the animal studies. Every effort was made to minimize suffering and the number of animals used in each experiment.
Construction of tissue-engineered nerves
Tissue-engineered nerves were constructed in vitro using Schwann cells differentiated from rat skin-derived precursors (SKPs) (SKP-SCs) as supporting cells and chitosan nerve conduits combined with silk fibroin fibers as scaffolds in a rotary perfusion cell culture (Rotary Culture MW TM ) bioreactor (Synthecon, Inc, Houston, TX, USA).
A clean 1-day-old female Sprague-Dawley rat was provided by the Experimental Animal Center of Nantong University, China (license No. SCXK (Su) 2008-0010). Briefly, approximately 2 cm 2 of dorsal skin was dissociated. The SKPs from this newborn Sprague-Dawley rat were isolated, cultured, induced to differentiate into SKP-SCs directly, and expanded in vitro (Toma et al., 2001; Biernaskie et al., 2006) . The suspension of SKP-SCs and scaffolds were placed in the rotary culture container filled with complete medium, which was cultured in an incubator at 37°C, 5% CO 2 , and rotational speed of 10 r/min to provide sufficient contact between the cells and scaffolds. The final cell density was 10 6 cells/mL. To allow scaffold suspension in the culture liquid, the rotational speed of the microgravity bioreactor was adjusted 24 hours after cell attachment. The tissue-engineered nerves were stored in normal saline after rinsing twice with normal saline.
Establishment of the sciatic nerve injury model
Three female, 2-month-old clean Sprague-Dawley rats were provided by the Experimental Animal Center of Nantong University, China (license No. SCXK (Su) 2008-0010). The animals were housed in a temperature-controlled environment and allowed free access to food and water. First, the rats were deeply anesthetized with an intraperitoneal injection of a compound anesthetic (chloral hydrate 4.25 g, magnesium sulfate 2.12 g, sodium pentobarbital 886 mg, ethanol 14.25 mL, and propylene glycol 33.8 mL in 100 mL) at a dose of 0.2-0.3 mL/100 g. An incision through the skin and muscle was made to expose the sciatic nerve at the The data are presented as the mean ± SD based on the three rats analyzed in this study. The new blood vessels were mainly capillaries and microvessels with diameters ranging from 9 to 301 μm. Blood vessels with diameters of 27 to 155 μm accounted for 82.84% of all vessels.
Figure 1 Schematic diagram of the analysis region.
The main portion of each tissue-engineered nerve (the part between the arrows) was selected for parameter analysis. The nerve stumps at the ends of the tissue-engineered nerves were excluded.
Figure 2 Tissue-engineered nerve after clearing with glycerin.
The proximal end is on the right, and the distal end on the left. The nerve stumps at the ends of the tissue-engineered nerves and connective tissues surrounding the tissue-engineered nerves were transparent. The chitosan nerve conduits appeared semitransparent. Both the small vessels in the nerve stumps and the microvessels growing into the tissue-engineered nerves were filled with blue contrast agent (arrows) and are clearly visible. The microvessels growing into the tissue-engineered nerves from the surrounding tissues are indicated with arrows.
Figure 3 Three-dimensional reconstructions of blood vessels in tissue-engineered nerve.
(A, B) Views from two different angles of a three-dimensional reconstruction. The proximal end is at the top, and the distal end at the bottom. The blood vessels of the popliteal fossa are indicated by the gray arrow. A large number of microvessels and capillaries were relatively well visualized. Microvessels growing into the tissue-engineered nerves are indicated with white arrows. New blood vessels grew into the tissue-engineered nerves from three main directions: the proximal end, the distal end, and the middle. The microvessels growing in from the middle part are indicated with white arrowheads. The microvessels connecting the proximal and distal ends are indicated with gray arrowheads. left mid-thigh. An 8-mm section of the sciatic nerve (from approximately 10 mm distal to the proximal end to the ischial tuberosity) was resected to produce a 10-mm gap after slight retraction of the distal and proximal stumps. A tissue-engineered nerve was implanted to bridge the gap, and the proximal and distal nerve stumps were each inserted 1 mm into either end of the conduit. Then, the muscle layers and skin were sutured closed in layers. After the surgery, the animals recovered in warm cages (Yang et al., 2011) .
Perfusion of contrast agents
Four weeks after surgery, the rats were again deeply anesthetized with the compound anesthetic. Each animal was infused with approximately 500 mL of normal saline mixed with 0.8 mL heparin sodium to a final concentration of 10 U/mL (Changzhou Qianhong Pharmaceutical Co., Ltd., Changzhou, Jiangsu Province, China) through a pinhead inserted into the left ventricle. Then, a blue-colored (MV-120) MICROFIL compound (MV 20 mL, diluent 25 mL, and curing agent 2.25 mL) (Flow Tech, Inc., Carver, MA, USA) was infused into the aorta with a 5-mL syringe. The perfusion was continued until the contrast agent outflow was observed from the right atrium and part of the liver turned blue. The perfusion pressure was approximately 100 cmH 2 O. The volume of contrast agents infused was approximately 40 mL. The working time of the MICROFIL compounds was 20 minutes from the addition of the curing agent to the other compounds. Finally, the root of the aorta was ligated with surgical sutures, and the rat was placed in a refrigerator at 4°C overnight to allow the contrast agents to cure.
Collection and treatment of samples
After the contrast agents had cured, the surgical site at the left mid-thigh was reopened to expose the tissue-engineered nerve. Then, the tissue-engineered nerve and nerve ends were harvested and cleared in glycerin. Each sample was placed in a 50% mixture of water and glycerin. At successive 24-hour intervals, the glycerin concentration was raised to 75%, 85%, and finally 100%. This procedure cleared the tissue to allow the microscopic examination to select a well-perfused region of the blood vessels for micro-CT scanning.
Scanning, parameter analysis, and three-dimensional reconstruction of blood vessels by micro-CT
The samples were scanned in a SkyScan1076 micro-CT (Bruker Corporation, Billerica, MA, USA) at 29 kV voltage, 169 μA current, and 8.8 μm resolution. Each sample took approximately 14 minutes to scan. Three-dimensional images of the blood vessels were reconstructed. The SkyScan CTVOX 2.1 software was used to automatically quantify several parameters, including percent object volume (%), structure thickness (mm), fragmentation index (1/mm), structure separation (mm), and percent porosity (%). Most of each tissue-engineered nerve was used when analyzing the parameters, but the nerve stumps at the ends of the tissue-engineered nerves were excluded (Figure 1 ).
Statistical analysis
The data are presented as the mean ± SD. The data were calculated and analyzed using the Stata 7.0 software package (Stata Corp., College Station, TX, USA).
Results
General appearance of the tissue-engineered nerves
The tissue-engineered nerve samples, after perfusion of the contrast agent, became transparent through dehydration in the glycerin gradient. The nerve stumps at the ends of the tissue-engineered nerves and connective tissues surrounding the tissue-engineered nerves were transparent, while the chitosan nerve conduits appeared semitransparent. After clearing, the tissue-engineered nerve samples could be observed and imaged directly under the light microscope. The microvessels filled with blue contrast agent were clearly visible, which was helpful for checking the effect of perfusion on the blood vessels to facilitate better three-dimensional image reconstruction (Figure 2 ).
Three-dimensional reconstructions of the blood vessels in the tissue-engineered nerves
Three-dimensional reconstructions of the blood vessels that formed after the tissue-engineered nerves were implanted in vivo were acquired through micro-CT scanning and subsequent image processing after perfusion of the contrast agent (Figure 3) . A large number of microvessels and capillaries were relatively well-visualized. New blood vessels had grown into the tissue-engineered nerves from three main directions: the proximal end, the distal end, and the middle, which is consistent with prior observations. In addition to the large number of visible microvessels growing into the tissue-engineered nerves, a few microvessels connecting the proximal and distal ends were also observed.
Parameter analysis of the three-dimensional blood vessel reconstructions
Quantitative parameter analysis was conducted on the three-dimensional reconstructions of the majority of the tissue-engineered nerves (Figure 1) . The parameters identified the number, diameter, connection, and spatial distribution of the blood vessels ( Table 1) . By further analyzing the blood vessel diameters, the proportion and distribution of neovascular diameters in the tissue-engineered nerves implanted in vivo were determined (Figure 4) . The new blood vessels were mainly capillaries and microvessels, and their diameters ranged from 9 to 301 μm. Blood vessels with diameters from 27 to 155 μm accounted for 82.84% of the vessels.
Discussion
No convenient and objective method for evaluating angiogenesis in tissue-engineered nerves that includes three-dimensional information on the new blood vessels has been reported. However, several detailed reports have examined angiogenesis in tissue-engineered nerves. The results of the present study suggest that the method of MICROFIL perfusion and micro-CT scanning is well-suited for imaging and evaluating angiogenesis in tissue-engineered nerves. Blood vessels can be visualized under the microscope using conventional or specialized staining of tissue sections, but these techniques cannot provide information on the spatial distribution of vessels (Jin et al., 2005; Oxlund et al., 2010; Marinković et al., 2013; Savransky et al., 2013; Wang et al., 2014a, c) . Three-dimensional reconstructions of blood vessels can be obtained based on tissue sectioning and staining, but this approach takes a lot of time and effort and requires advanced tissue slicing technology. It is difficult to avoid the loss of objective information during tissue slicing. Blood vessels can also be visualized by perfusion. For example, resin and ink are common perfusion agents for visualizing vessels with large diameters because they fill the vessels incompletely and insufficiently. Furthermore, these agents do not allow direct scanning (Kanzaki et al., 1982; Cheung, 1996; Walter et al., 2012; Hasan et al., 2013; Xue et al., 2014) .
Blood vessel three-dimensional reconstruction using MI-CROFIL perfusion and micro-CT scanning is convenient, feasible, and visualizes microvessels well (Garcia-Sanz et al., 1998; Nyangoga et al., 2011; Barbetta et al., 2012; Jing et al., 2012; Liu et al., 2013; Kline et al., 2014; Lee et al., 2014) . The method contains two steps: blood vessel perfusion with the MICROFIL compounds, and micro-CT scanning of the tissue samples. Both stages are important for producing the best three-dimensional reconstructions of the blood vessels. The technical procedure and necessary precautions during blood vessel perfusion (i.e. the preparation of the tissue samples) are more detailed than the micro-CT scanning.
During perfusion, normal saline and contrast agents must be prevented from entering the pulmonary circulation or the microvessels will not be filled well because of insufficient pressure. The flow should be well-distributed and the pressure should be constant when the contrast agents are injected using a syringe. Too little pressure causes inadequate filling of the microvessels, while too large a pressure causes blood vessels to burst. In addition, air bubbles must be prevented from entering the blood vessels. The ligation of the root of the aorta must be performed immediately following the perfusion to prevent the contrast agents from flowing out before the contrast agent compounds have time to cure.
The selection of the voltage for micro-CT scanning should be decided while considering the number of microvessels, the amount of tissue surrounding the blood vessels, and the continuity of the vessels. The diameter of the thinnest capillary is approximately 10 μm. The spatial resolution of the micro-CT must be at least that size to image the smallest vessels. In addition to the above factors, the limitations of the MICROFIL contrast agent compounds and micro-CT themselves should also be considered. With the advancement of experimental technologies and instruments, three-dimensional imaging of blood vessels will become more and more sophisticated, objective, and accurate.
One significant advantage of this technique is that relevant quantitative data on the blood vessels (the number, diameter, connection, and spatial distribution) can be obtained from the three-dimensional reconstructions of the blood vessels in the tissue-engineered nerves using the parameter analysis software bundled with the scanning system. Thus, a more objective and comprehensive understanding of angiogenesis in tissue-engineered nerves implanted in vivo was acquired. The quantitative nature of the data allows us to objectively compare the differences and changes in angiogenesis in tissue-engineered nerves implanted in vivo under different conditions. This provides a better method and premise for exploring the factors that promote angiogenesis in tissue-engineered nerves, as well as further revealing the relationship between angiogenesis and nerve regeneration.
As experimental techniques advance, more comprehensive and objective imaging methods for visualizing angiogenesis in tissue-engineered nerves will appear. However, blood vessel three-dimensional reconstruction using MICROFIL perfusion and micro-CT scanning is currently a good method for visualizing newly formed blood vessels in tissue-engineered nerves implanted in vivo and provides an experimental basis for further research on nerve regeneration.
